This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, The Broad Institute, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12,268 
1 out of 488 
Years Active: 2025
Title: Léa Aurelie Bouché: Innovator in Cancer Treatment
Introduction
Léa Aurelie Bouché is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Léa holds a patent for "Acyl sulfonamides for treating cancer." This invention provides acyl sulfonamide compounds of general formula (I), which are designed to offer new therapeutic options for cancer patients. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Léa has worked with prominent organizations, including Bayer Aktiengesellschaft and The Broad Institute, Inc. His experience in these esteemed institutions has allowed him to refine his expertise and contribute to groundbreaking research in oncology.
Collaborations
Léa has collaborated with talented individuals in his field, including Daniel Korr and Antonius Ter Laak. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Léa Aurelie Bouché is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovative research in medicine. His contributions continue to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile